ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
The prevalence of gastrointestinal dysfunction and its impact on quality of life in Parkinson's disease.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence.Brain, behavior, & immunity - health · 2026Article
- Article
- Development and emerging trends in gastrointestinal dysfunction of Parkinson's disease: a decade-long bibliometric analysis.Frontiers in aging neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal (GI) dysfunction is one of the most common and earliest non-motor symptoms (NMS) in Parkinson's disease (PD). We aimed to study the prevalence and severity of GI dysfunction and its impact on quality of life (QoL) in patients with PD. This was a single-centre, questionnaire-based cross-sectional study enrolling 150 PD patients meeting the UKPDS Brain Bank criteria with a minimum disease duration of 5 years. An equal number of age-matched healthy controls (HC) were included. A detailed clinical and neurological evaluation was followed by five GI, other NMS and QoL scales. The mean age of PD patients was 53.69 ± 11.79 years, and 51.83 ± 10.91 years in HC (p = 0.16). Women comprised 37.3% of PD patients and 46.7% of HC (p < 0.001). The most common GI dysfunction in PD patients was constipation, followed by bloating and drooling. Compared to HC, PD patients had a significantly higher prevalence of drooling, dysphagia, sweet food preference, bloating, heartburn and constipation (p < 0.001). PD patients also had significantly higher severity of heartburn and constipation (p < 0.001). Duration of constipation correlated with other NMS and autonomic dysfunction (p < 0.003). Malnutrition in PD patients was associated with higher cognitive impairment. The GI dysfunction led to worse QoL in PD patients than in HCs (p < 0.001). GI dysfunction in PD patients is associated with higher NMS and worse QoL, which is an important area for intervention.
Indexed as
Identifiers
41171382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.